Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee*: National Institute on Drug Abuse Special Emphasis Panel; Multi-site Clinical Trials.                    

*Date*: October 19, 2017.                    

*Time*: 1:00 p.m. to 5:00 p.m.                    

*Agenda*: To review and evaluate grant applications.                    

*Place*: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person*: Shang-Yi Anne Tsai, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, Room 4228, MSC 9550, Bethesda, MD 20892, 301-827-5842,                         *shangyi.tsai@nih.gov*.                    

*Name of Committee*: National Institute on Drug Abuse Special Emphasis Panel; NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12).                    

*Date*: October 25, 2017.                    

*Time*: 9:00 a.m. to 12:00 p.m.                    

*Agenda*: To review and evaluate grant applications.                    

*Place*: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852.                    

*Contact Person*: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,                         *mcguireso@mail.nih.gov*.                    

*Name of Committee*: National Institute on Drug Abuse Special Emphasis Panel; NIH Pathway to Independence Award (K99/R00).                    

*Date*: October 25, 2017.                    

*Time*: 1:00 p.m. to 5:00 p.m.                    

*Agenda*: To review and evaluate grant applications.                    

*Place*: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852.                    

*Contact Person*: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,                         *mcguireso@mail.nih.gov*.                    

*Name of Committee*: National Institute on Drug Abuse Special Emphasis Panel; (T32) Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants.                    

*Date*: October 26-27, 2017.                    

*Time*: 8:00 a.m. to 5:00 p.m.                    

*Agenda*: To review and evaluate grant applications.                    

*Place*: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852.                    

*Contact Person*: Susan O. McGuire, Ph.D. Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,                         *mcguireso@mail.nih.gov*.                    

*Name of Committee*: National Institute on Drug Abuse Special Emphasis Panel; Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01, R21).                    

*Date*: November 1, 2017.                    

*Time*: 9:00 a.m. to 5:00 p.m.                    

*Agenda*: To review and evaluate grant applications.                    

*Place*: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852,                    

*Contact Person*: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,                         *mcguireso@mail.nih.gov*.                    

*Name of Committee*: National Institute on Drug Abuse Special Emphasis Panel; Cutting-Edge Basic Research Awards (CEBRA) (R21).                    

*Date*: November 29, 2017.                    

*Time*: 9:00 a.m. to 5:00 p.m.                    

*Agenda*: To review and evaluate grant applications.                    

*Place*: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                              ( print page 46253)    

*Contact Person*: Shang-Yi Anne Tsai, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, Room 4228, MSC 9550, Bethesda, MD 20892, 301-827-5842,                         *shangyi.tsai@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: September 28, 2017.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-21265 Filed 10-3-17; 8:45 am]

 BILLING CODE 4140-01-P